Browsing by Author Henshall, Susan M.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 21  next >
Issue DateTitleAuthor(s)Citation
2006Aberrant neuropeptide Y and macrophage inhibitory cytokine-1 expression are early events in prostate cancer development and are associated with poor prognosis.Horvath, Lisa; Kench, James; Lee, Cheok; Biankin, Andrew V.; Breit, Samuel N; Brenner, Phillip C.; Brown, David A.; Delprado, Warick; Gardiner-Garden, Margaret; Golovsky, David; Grygiel, John J.; Henshall, Susan M.; Kooner, Raji; O'Neill, Gordon F.A.; Rasiah, Krishan K.; Stricker, Phillip D.; Sutherland, Robert L.; Turner, Jennifer Jane; Central Clinical School: Medicine; School of Medical Sciences: Pathology; Central Clinical School: MedicineAberrant neuropeptide Y and macrophage inhibitory cytokine-1 expression are early events in prostate cancer development and are associated with poor prognosis., Cancer Epidemiology Biomarkers & Prevention 2005, vol.15,(4),2006,pp 711-716
2008Androgen regulation of multidrug resistance-associated protein 4 (MRP4/ABCC4) in prostate cancerAllen, John; Handelsman, David; Grygiel, John J.; Henshall, Susan M.; Ho, Lye Lin; Horvath, L G; Kench, James; Scheffer, George; Stricker, Phillip D.; Sutherland, Robert L.; Central Clinical School: Centenary Institute; Concord Clinical School: ANZAC Research InstituteAndrogen regulation of multidrug resistance-associated protein 4 (MRP4/ABCC4) in prostate cancer, The Prostate, vol.68, 13, 2008,pp 1421-1429
2009BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breastMcNeil, Catriona; O'Toole, Sandra; Anderson, Luke R.; Biankin, Andrew V.; Butt, Alison Joy; Crea, P; Henshall, Susan M.; Millar, E.; Morey, Adrienne; Musgrove, Elizabeth A.; Pinese, Mark; Sutherland, Robert L.; Western Clinical School: Medicine (Westmead); Central Clinical School: PathologyBAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast, British Journal of Cancer, vol.100, 1,pp 123-133
2006A distinct molecular profile associated with mucinous epithelial ovarian cancer.Baron-Hay, Sally; Scolyer, Richard; Scott, Carolyn; Bali, A.; et, al; Fink, Daniel; Gardiner-Garden, Margaret; Hacker, Neville F.; Heinzelmann-Schwarz, Viola A.; Henshall, Susan M.; Scurry, Jame P.; Smith, Alison N.; Vanden Bergh, P.; Clinical Schools; Central Clinical School: Pathology; Northern Clinical School: Molecular Medicine (Kolling I)A distinct molecular profile associated with mucinous epithelial ovarian cancer., British Journal of Cancer, vol.94,(6),2006,pp 904-913
2002DPC4/Smad4 Expression and Outcome in Pancreatic Ductal AdenocarcinomaLee, Cheok; Biankin, Andrew V.; Biankin, S. A.; Head, D. R.; Henshall, Susan M.; Hook, Henry C.; Hugh, Thomas B.; Kench, James; Morey, Adrienne; Sutherland, Robert L.; Central Clinical School: MedicineDPC4/Smad4 Expression and Outcome in Pancreatic Ductal Adenocarcinoma, Journal of Clinical Oncology, vol.20,(23),2002,pp 4531-4542
2003EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancerCampbell, Ian; Davies, Michael; Mann, Graham; Anderson, David W; Bova, Ronaldo J; Brady, Ged; Choong, David YH; Clancy, Jennifer L; Hacker, Neville F.; Henderson, Michelle J; Henshall, Susan M.; Macdonald, Graeme A; Nolan, Tania; Olopade, Olufunmilayo I; Russell, Amanda J; Segara, Davendra; Sutherland, Robert L.; Watts, Colin KW; Woollatt, Erica; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Heart Research Institute; Western Clinical School: Westmead Millennium InstituteEDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer, Oncogene, vol.22,(32),2003,pp 5070-5081
2011Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer BiomarkersHorvath, Lisa; Kench, James; Coolen, Marcel; Devaney, James; et al, various; Henshall, Susan M.; Hulf, Toby; Patterson, K I; Qu, Wenjia; Song, Jenny; Statham, Aaron; Stirzaker, Clare; Tabor, Bruce; Central Clinical School: Medicine; School of Medical Sciences: PathologyEpigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers, Cancer Epidemiology, Biomarkers and Prevention, vol.20, 1, 2011,pp 148-159
2008Expression of LMO4 and outcome in pancreatic ductal adenocarcinomaBiankin, Andrew; Kench, James; Colvin, E K; Cosman, P H; Henshall, Susan M.; Lee, C Soon; Lindeman, Geoffrey J; Murphy, N C; Musgrove, E A; Scarlett, C J; Sum, Eleanor Y M; Susanto, J; Sutherland, Robert L.; Visvader, Jane E; Medicine Faculty Office; School of Medical Sciences: PathologyExpression of LMO4 and outcome in pancreatic ductal adenocarcinoma, British Journal of Cancer, vol.98,(3),2008,pp 537-541
2001Frequent Loss of Estrogen Receptor-beta Expression in Prostate CancerLee, Cheok; Brenner, Phillip C.; Delprado, Warick; et, al; Golovsky, David; Head, Darren R.; Henshall, Susan M.; Horvath, Lisa G.; Makela, S; O'Neill, Geraldine M.; Quinn, David I.; Central Clinical School: MedicineFrequent Loss of Estrogen Receptor-beta Expression in Prostate Cancer, Cancer Research, vol.61, N/A,pp 5331-5335
2009Identification of candidate biomarkers of therapeutic response to docetaxel by proteomic profiling.Boyer, Michael; Pavlakis, Nick; Stockler, Martin; Breit, Samuel N; Brown, David A.; Henshall, Susan M.; Horvath, L G; Kaplan, Warren; Lee, Brian; Marx, Gavin; Molloy, Mark; Sutherland, Robert L.; Zhao, Liangli; Central Clinical School: Medicine; Northern Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials CentreIdentification of candidate biomarkers of therapeutic response to docetaxel by proteomic profiling., Cancer Research, vol.69, 19,pp 7696-7703
2008Immunohistochemical level of unsulfated chondroitin disaccharides in the cancer stroma is an independent predictor of prostate cancer relapse.Horvath, Lisa; Butler, Miriam S.; Byers, Sharon; Henshall, Susan M.; Horsfall, David J.; Kench, James; Marshall, Villis R; Reinboth, Betty J.; Ricciardelli, Carmela; Sakko, Andrew J.; Stahl, Jurgen; Stricker, Phillip D.; Sutherland, Robert L.; Tilley, Wayne D.; Central Clinical School: MedicineImmunohistochemical level of unsulfated chondroitin disaccharides in the cancer stroma is an independent predictor of prostate cancer relapse., Cancer Epidemiology, Biomarkers and Prevention, vol.17, 9, 2008,pp 2488-2497
2011Low AZGPI Expression Predicts for Recurrence in Margin-Positive, Localized Prostate CancerKench, James; Lee, Cheok; Henshall, Susan M.; Horvath, Lisa G.; Pe Benito, Ruth; Rasiah, Krishan K.; Stricker, Phillip D.; Sutherland, Robert L.; Yip, Po Yee; School of Medical Sciences: Pathology; Central Clinical School: MedicineLow AZGPI Expression Predicts for Recurrence in Margin-Positive, Localized Prostate Cancer, The Prostate, vol.71, 15, 2011,pp 1638-1645
2005Lower levels of nuclear beta-catenin predict for a poorer prognosis in localized prostate cancer.Horvath, Lisa; Kench, James; Lee, Cheok; Brenner, Phillip C.; Golovsky, David; Grygiel, John J.; Henshall, Susan M.; Kooner, Raji; O'Neill, Gordon F.A.; Stricker, Phillip D.; Sutherland, Robert L.; Central Clinical School: Medicine; School of Medical Sciences: Pathology; Central Clinical School: MedicineLower levels of nuclear beta-catenin predict for a poorer prognosis in localized prostate cancer., International Journal of Cancer, vol.113,(3),2005,pp 415-422
2009Margin Clearance and Outcome in Resected Pancreatic CancerGill, Anthony; Kench, James; Biankin, Andrew V.; Chang, David K.; Colvin, E K; Cosman, P H; Henshall, Susan M.; Johns, Amber; Kelly, Mark; Leong, Rupert; Merrett, Neil D; Nguyen, Nam; Scarlett, Christopher; Sutherland, Robert L.; Northern Clinical School: Pathology; School of Medical Sciences: PathologyMargin Clearance and Outcome in Resected Pancreatic Cancer, Journal of Clinical Oncology (Print), vol.27, 17,pp 2855-2862
2004Membranous Expression Of Secreted Frizzled-Related Protein 4 Predicts For Good Prognosis In Localized Prostate Cancer And Inhibits Pc3 Cellular Proliferation In Vitro.Kench, James; Lee, Cheok; Brenner, Phillip C.; Golovsky, David; Grygiel, John J.; Henshall, Susan M.; Horvath, L G; Kooner, Raji; O’Neill, Gordon F.; Saunders, Darren N.; Stricker, Phillip D.; Sutherland, Robert L.; School of Medical Sciences: Pathology; Central Clinical School: MedicineMembranous Expression Of Secreted Frizzled-Related Protein 4 Predicts For Good Prognosis In Localized Prostate Cancer And Inhibits Pc3 Cellular Proliferation In Vitro., Clinical Cancer Research, vol.10,(2),2004,pp 615-625
2009Messina: A Novel Analysis Tool to Identify Biologically Relevant Molecules in DiseaseKench, James; Biankin, Andrew V.; Colvin, E K; Henshall, Susan M.; Pinese, Mark; Scarlett, C J; Segara, Davendra; Sutherland, Robert L.; School of Medical Sciences: PathologyMessina: A Novel Analysis Tool to Identify Biologically Relevant Molecules in Disease, PLoS One, vol.4, 4, 2009,pp e5337-1-e5337-7
2004Pancreatic Intraepithelial Neoplasia In Association With Intraductal Papillary Mucinous Neoplasms Of The Pancreas: Implications For Disease Progression And Recurrence.Soon, Lee; Biankin, Andrew V.; Biankin, Sandra A.; Coleman, Maxwell J.; Dijkman, Floriaan P.; Henshall, Susan M.; Kench, James; Morey, Adrienne; Sutherland, Robert L.; School of Medical Sciences: PathologyPancreatic Intraepithelial Neoplasia In Association With Intraductal Papillary Mucinous Neoplasms Of The Pancreas: Implications For Disease Progression And Recurrence., American Journal of Surgical Pathology, vol.28,(9),2004,pp 1184-1192
2011Pathways of chemotherapy resistance in castration-resistant prostate cancerHorvath, Lisa; Mahon, Kate; Henshall, Susan M.; Sutherland, Robert L.; Central Clinical School: Medicine; School of Public Health: Public HealthPathways of chemotherapy resistance in castration-resistant prostate cancer, Endocrine-Related Cancer, vol.18, 4, 2011,pp R103-R123
2009A role for GATA-2 in transition to an aggressive phenotype in prostate cancer through modulation of key androgen-regulated genes.Kench, James; Bohm, M; Henshall, Susan M.; Locke, W; Sutherland, Robert L.; School of Medical Sciences: PathologyA role for GATA-2 in transition to an aggressive phenotype in prostate cancer through modulation of key androgen-regulated genes., Oncogene: including Oncogene Reviews, vol.28, 43,pp 3847-3856
2007Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancerLee, Cheok; Grygiel, John J.; Henshall, Susan M.; Horvath, Lisa G.; Kench, James G.; Lelliott, Jayne E.; Saunders, Darren N.; Sutherland, Robert L.; Williams, Elizabeth D.; School of Medical Sciences: PathologySecreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer, Prostate, vol.67,(10),2007,pp 1081-1090